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Cell division
in vivo is carefully regulated. The physical proximity of neighbouring cells and changes in cell shape both have direct effects on the progression through the cell cycle (Stebbing & Heath 1984; Folkman & Moscona 1978) , but the primary control mechanism is biochemical. The extracellular space in a normal tissue contains a wide range of growth regulating chemicals, and each stage of the cell cycle occurs at a rate dependent on the concentrations of these chemicals (Baserga 1985 , chapters 10 and 11). Such a complex control mechanism ensures a rapid response to changes in cell density, such as occurs in wound healing (Sprugel etal. 1987; Sherratt & Murray 1990 .
Growth-regulating chemicals can be of several types. Firstly, they can be either activators or inhibitors of cell division. In addition, their action can be autocrine or paracrine, that is, they can be produced either by the cell type on which they act or only by other cell types. At a greater level of detail, different chemicals affect different portions of the cell cycle. Homeostasis therefore requires a wide range of mitotic regulators.
One of the characteristics of cancer cells is their escape from these biochemical control mechanisms. Such escape is probably not sufficient to generate cancer: in particular, the cells of benign tumours often express oncogenes ( Volpe 1990 ). Over the last decade, an intensive programme of experimental research has led to a partial understanding of the genetic mechanisms by which cancer cells escape from biochemical growth control, namely mutations which cause the expression of oncogenes or the loss of anti-oncogenes. The former are genes causing excessive cell proliferation, whereas anti-oncogenes act to limit the division rate of normal cells. In either case, mutation results in a cell with a proliferative advantage compared with the normal cells around it. These rapidly dividing mutant cells are often the first step in a series of genetic transformations which result in cancer.
The role of biochemical regulators of mitosis in tumour growth has been investigated in several theoretical studies. Several authors have incorporated chemical inhibitors of cell division into models of tumour growth that is limited by the uptake of nutrients, showing that the growth rate and diffusionlimited size of a tumour (typically a few millimetres in diameter) both depend on the parameters of this mitotic inhibition (Greenspan 1972 (Greenspan , 1974 Bhargava 1977; Tarumi & Schwegler 1983) . Glass (1973) focused on the inhibition aspect and developed a simple model which suggested that proliferative inhibition alone could be sufficient to limit tumour growth, depending on the mitotic parameters. This work has recently been extended to include more general geometries and spatial non-uniformities (Shymko & Glass 1976; Adam 1986 Adam , 1987 ). These models of diffusion-limited growth can also be applied to vitro multicell spheroids (Durand 1990; Swan 1992) . The role of mitotic control in carcinogenic mutations was considered by Wheldon (1975) , who divided such mutations into two types, according to whether the detection or production of a mitotic inhibitor was affected. Also, Bell (1976) used a stochastic model to investigate the possible failure of mutant cells to secrete a mitotic inhibitor, and derived an expression for the probability of a single m utant cell giving rise to a macroscopic tumour of a given size. More recently, Michelson & Leith (1991) have compared the effects of autocrine and paracrine growth factors by varying the parameters in a logistic model for tissue growth.
M OD ELLING THE ESCAPE FROM M IT O T IC CO N TR O L
The division of normal cells is regulated both directly by the local cell density and by the combined effect of a number of synergistic growth factors. We model this by taking the division rate per cell to be given by R0 r ( n ) q (q ) . ..q(q),w here n(x, t) is the cell density, and ct(x, t) (1 ^ i^ j) are the concentrations of thej mitotic regulators, with x and t denoting space and time coordinates. Thus we approximate the real situation of an integer number of cells by a continuum variable for cell density. The decreasing function r(n) reflects the effect of crowding on cell density, which we include although it is not essential feature of the model, and q(q) represents the effect on the cell division rate of chemical i .Thus q is an increasing function if chemical i is a mitotic activator, and a decreasing function for a mitotic inhibitor. In normal tissue, the cell density and chemical concentrations are in an equilibrium state, which we assume to be spatially homogeneous, with the growth rate R0 balanced by an equal rate of cell death. We denote this equilibrium state by , q = c\ (1 ^ i < j) ,a n d we assume that r{ne) = q(c®) = 1 (1 Oncogenic mutations can modify this division rate in several ways.
1. Increased response to a mitotic activator. This can result from the expression of an oncogene such as erb B, whose oncoprotein is a truncated version of the receptor to the mitotic activator epidermal growth factor (Downward et al. 1984) . Another possible cause is the loss of an anti-oncogene such as the neuro fibromatosis tumour suppressor gene, which in normal cells produces a protein inhibiting ^-m ed iated mitotic activation (Xu et al. 1990) . We model such a mutation by assuming that mutant cells detect the extracellular concentration ol the activator to be times its real value, with E , > 1.
cell migration
2. Decreased response to a mitotic inhibitor. This can be caused by the loss of an anti-oncogene, for example, the rb (retinoblastoma) gene, whose ex pression in normal cells reduces the responsiveness to the mitosis-inhibiting effects of type /? transforming growth factor (Kimchi al. 1987; Parkinson & Balmain 1990) . A second example is the dcc (deleted in colon carcinoma) gene, whose product is the receptor for a mitotic inhibitor, although the inhibitor itself has not yet been identified . We model a mutation of this kind by again assuming that the m utant cells detect the concentration of the inhibitor to be E , times its real value, but w this case.
3. Increased production of a mitotic activator. Two types of mutation have this effect. The first is typified by the ras gene, whose cytoplasmic oncoprotein stimulates the production of several different growth activators (Jakowlew et al. 1988; Rayter et al. 1989) . The second is the expression of an oncogene whose oncoprotein is very similar to a particular mitotic activator. Examples of this are whose protein is very similar to platelet-derived growth factor (Doolittle et al. 1983) , and i n t -2 , whose protein is relate fibroblast growth factor (Dickson & Peters 1987 ). In our model, such mutations do not have a direct effect on the cell growth rate: rather, they affect the equation for chemical conservation.
4. Decreased production of a mitotic inhibitor. If a cell produces an auto-inhibitor of cell division then the gene corresponding to this inhibitor is clearly a potential anti-oncogene, and, in our model, the chemical conservation equation is again affected. The existence and properties of such mitotic auto-inhibitors are very well documented (see Iversen (1981) for review), but the corresponding genes remain to be characterized.
5. Escape from biochemical dependence. The ex pression of oncogenes can stimulate intracellular signals that normally occur only in response to a mitotic activator. Such oncogenes are of two types. The first have oncoproteins that act within the cell cytoplasm: an example of this is the abl gene, which triggers signals normally generated by the growth-activating chemical GM-CSF (Kelly 1985; Cook al. 1985) . The second type act within the nucleus to remove cell division from its dependence on cytoplasmic signals: an example is the myc gene (Eisenman 1989) . We model mutations of this kind by adding a constant term s0 to the product q (q) ...q ( q ) i n the division rate per mutant cell.
Detailed reviews of the mechanisms by which oncogenes promote cell division are given by ) and Aaronson (1991) ; anti-oncogenes have been reviewed by Sager (1989) and Weinberg (1991) .
We denote by m(x,t) the density of mutant cells. In a mixed population of normal and mutant cells, the crowding term in the mitotic rate depends on the sum of these cell densities, so that the conservation equations for normal and mutant cells have the following form:
biochemically regulated cell division cell death
Here we assume that any m utation in the response to extracellular regulators occurs with respect to chemical 1. Following a num ber of previous studies (M urray 1989; Sherratt & M urray 1990) , we use linear diffusion to model cell migration, and we take cell death to be a first order process. This representation of cell growth takes no account of possible limits on the supply of nutrients, and is thus only applicable to very early stages of tum our growth.
The remaining model equations are conservation equations for the concentrations of they chemicals. The form of these depend on whether the chemical is an autocrine or paracrine regulator, and we consider the ditions to correspond to the m utation of a single cell at the origin, so that
where L is half a typical cell length. As the size of the tissue is very large compared with the submacroscopic tumours we are considering, we take the spatial domain to be infinite. Moreover, there will be no disturbances far from the site of m utation, so that the appropriate boundary conditions are 0, c = c\ at v = + oo (1 ^ i ^j ) . We non-dimensionalize this system by using the following rescalings:
Henceforth we omit the asterisks for notational simplicity. The dimensionless governing equations can then be written in the following general form :
and
general case in which chemical is produced at a constant rate
Pt, independent of cell density, and also at a rate pi (n + m) per cell. Intuitively, we expect to be either constant or increasing if chemical i is a mitotic inhibitor, and constant or decreasing for a mitotic activator. If chemical ii s normally produced in a purely autocrine way, then Pt = 0, whereas if it is a purely paracrine factor, pt = 0. Thus we have subject to
Here we take the decay of active chemical to be a simple first order process, with rate constant dp, the fact that n = ne, m = 0, ct = c \ (1 ^ i ^ is an equilibrium state in the absence of mutations implies that dt = (Pj+ Pi(ne) ne) / ce t . The positive constant is the chemical diffusion coefficient.
In either the autocrine or paracrine case, a mutation which affects the production of chemical has the effect of adding the term Plmpt (n + m) to the right-hand side of the conservation equation. In the activator case, H > 0, and the mutation causes either increased pro duction of an autocrine factor or the triggering of the auto-production of a paracrine chemical that is normally produced only by other cell types. In the inhibitor case, this mutation is only relevant for an autocrine factor and corresponds to a reduced pro duction rate of this chemical, so that 0 > -1. The equations (1) and (2) constitute our model. We consider these equations in one space dimension, which renders the system amenable to mathematical analysis. Numerical solutions in two and three dimensions with radial symmetry are qualitatively very similar to these one-dimensional solutions; we have not investigated the effects of asymmetries. We take the initial con-(2 ^ i ^ j). As previously, we assume that any m utation affecting the response to, or production of, chemicals by the cells occurs with respect to chemical 1. Usually, only one of (£-1), 50 and H will be non zero, although an oncogene whose protein is a truncated growth factor receptor, such as erb B, might result in £ > 1 and 5 0 > 0 (Downward et al. 1984) .
PA RA M ETER VALUES AND M OD EL SO L U T IO N S
In addition to a number of parameters, the system (3) depends on the functions r(n), st(c{) and
(1 ^ i ^ j ) , which remain undetermined except for the constraint that r(l) = ^(1) = 1, for all The function r(n) is strictly decreasing, and we take r(n) = (N -n)/ (N -1), so that the dimensionless quantity Ais an upper bound on the cell density, due to crowding effects. If chemical i is an activator of cell division, then s{(c{) is strictly increasing, whereas pf(n) is either constant or decreasing, because an increase in cell density will result in either no change or a decrease in the production rate per cell of a mitotic activator. In this case, following Sherratt & M urray (1990 Sherratt & M urray ( , 1991 Sherratt & M urray ( , 1992 , we take = a,i + (1 -a 4) ct, and A*(l + fit) /( l + Pin2), where o q e (0 ,1) and ^,^e ( 0 , oo). In the inhibitor case, si(ci) is strictly decreasing, whereas pt(n) is either constant or increasing, and we take q(q) = k j [ \ + (* ,-1 ) q], and pf(n) ht ( l+ fit ri)/ (1 +/?,•), where k{ e (1, oo) and, as above, (0, oo). A simple biological requirement of the model is that, when n = c( = 1 and m = 0, as in normal tissue, the system should be stable to small local perturbations in the cell density n. In Appendix 1, we discuss the constraints that this imposes on the kinetic parameter values. Several of the model parameters can be estimated biologically. Equation (3a) gives a cell cycle time of Rq 1 log 2 in normal tissue, for which a typical order of magnitude is about 100 h. We therefore take R0 = (1/100) log 2 IT1 % 7 x 10-3 A_1. Previous model ling experience (Murray 1989; Sherratt & M urray 1990; Sherratt etal. 1992) suggests that a typical order of magnitude for a cell diffusion coefficient vivo is 10_locm2 s-1 or 10-11 cm2 s-1. With a cell length of 10 pm and the above value for , this gives K 0.01. Biochemicals of fairly large molecular mass, such as growth factors, will have a diffusion coefficient about 100 times larger than that of cells in vivo (Sherratt & M urray 1990; Sherratt et a l . 1992) , each ihave an order of magnitude of about 1. A final restriction is that we anticipate the chemical kinetics to be fast compared with cell division, so that hi > 1 when chemical ii s an autocrine regulator, and > 1 in paracrine case. However, beyond these intuitive considerations, which have been used previously (see, for example, Wheldon 1975), we are not aware of experimental data that would enable these production rates to be estimated quantitatively.
We have solved the model equations (3) subject to (4) numerically for a wide range of parameter values within these constraints. O ur simulations show that the different mutations discussed above give quite different types of behaviour. Mutations affecting the response to a mitotic regulator (|£-1| > 0), or giving an escape Figure 1 . The initial growth of a tumour cell population after a mutation which causes increased response to a mitotic activator, decreased response to a mitotic inhibitor, or partial escape from biochemical regulation of mitosis. We plot the density of (a) normal and ( b) mutant cells ( corresponding regulatory biochemicals (q and c2) as functions of distance x from the site of the mutation, at equally spaced times (dimensionless time interval = 3); the arrows indicate the way in which the solution changes as t increases. The solution has the form of an advancing wave of tumour cells and a receding wave of normal cells, with associated waves of regulatory chemicals. This is the qualitative form of the solution whenever j > 0 or |£ -1| > 0. The dimensionless parameter values are s0 = 2, £ = 2.5, D = 0.01, = with oq = 0.1, hx = 18, /?x = 10, Pl -0 and Dl -1 0.1, P2 = 10 and D2 = 2. Thus, chemical 1 is produced in a purely autocrine way, whereas the production of chemical 2 is part autocrine and part paracrine. The solution is obtained by solving (3) subject to (4) numerically, using a finite difference scheme. Figure 2 . The initial growth of a tumour cell population after a mutation which causes increased production of an autocrine mitotic activator, decreased production of an autocrine inhibitor, or which initiates auto-production of a mitotic activator that is normally produced only in a paracrine way. We plot the density of (a) normal and (b) mutant cells ( na nd m ,r espectively) and (c) and (d) the concentrations of the corresponding regulatory biochemicals (q and c2) as functions of distance xf rom the site of the mutation, at equally spaced times (dimensionless time interval = 300 the arrows indicate the way in which the solution changes as t increases. The solution has the form of an increase in both normal and mutant cell densities near the origin, followed by a gradual spread outwards of both cell types. Note the long timescale compared with that in figure 1 . The dimensionless parameter values are the same as in figure 1 , except that = 0, £ = 1 and H -4. The solution is obtained by solving (3) subject to (4) numerically, using a difference scheme. from biochemical dependence (50 > 0), result in an advancing wave of m utant cells and a receding wave of normal cells, as illustrated in figure 1. Such a solution corresponds to a rapidly growing tumour with the cell density in the tumour greater than that in normal cells. The value of the tumour cell density increases with both and |£-1|, as does the speed with which the tumour grows. We should stress that, well before the tumour becomes macroscopic, the equations (3) cease to be an adequate representation of the factors controlling tumour growth because the supply of nutrients and the development of a necrotic core within the tumour become crucially im portant (see Wheldon (1988, chapter 5) for review). Here we are only concerned with the very early stages after transformation.
In sharp contrast, mutations affecting the pro duction of a mitotic regulator do not result in an advancing wave of m utant cells. Rather, the density of both normal and m utant cells increases near the origin, and there is then a gradual spread outwards of both cell types (figure 2). This marked qualitative difference between mutations affecting the response to, and production of, mitotic regulators was noted previously by Wheldon (1975) in a simpler, spatially homo geneous model for tumour growth. The difference is clearly illustrated in figure 3 by plotting the total num ber of normal and m utant cells in a given region of the tissue, as a function of time, in the two cases. In the former case, the num ber of normal cells decreases as they are replaced by a higher density of m utant cells; in the latter, the num ber of both cell types increases much more slowly.
TH E EFFEC T OF AN IM M U N E RESPO N SE
The ability of the immune system to selectively kill the cells of at least some experimental cancers has long been recognized (Foley 1953; Baldwin 1955) , and the very rare spontaneous disappearance of hum an cancer is often attributed to a successful immune response (Kaiser 1989) . Despite recent research work on the characterization of tumour antigens (Sikora & James 1991), many aspects of the immune response to cancer time, t time, t (b)A mutation affecting the production of values as in figure 2 ). In the former case, there is a rapidly growing tumour, with normal cells being replaced by a higher density of mutant cells. In the latter case, there is a much slower increase in the number of both cell types. This figure clearly illustrates the totally different consequences of the different types of mutation. The solutions are obtained as in figures 1 and 2.
remain poorly understood (Naftzger & Houghton 1991) . Nevertheless, immunotherapy, in which the natural immune response is enhanced, is one of the most rapidly developing cancer treatments (Rosenberg 1988; Topalian & Rosenberg 1990; Morton & Economou 1990) . Experience with immune suppressed and aids patients suggests that a significant immune response may occur only for a minority of tumours (Beral et al. 1991) , although the short life expectancy of these patients means that this does not exclude the importance of immunosurveillance more generally.
Several mathematical models have been proposed for this immune response. and developed a deter ministic ordinary differential equation model for tumour cells and 'immune cells', based on an ecological predator-prey model. Grossman & Burke (1980) used a similar approach to show that both small and large tumours can escape immune surveillance, and Albert et al. (1980) determined the conditions for immune suppression of cancer in a predator-prey model with time-varying parameters. More recently, Hiernaux & Lefever (1988) Here, we use a very simple representation of the immune response to cancer, by assuming that mutant cells are subject to an additional first order death rate, with dimensionless rate constant 8. Thus, we add the term -8m to the right-hand side of equation {3b). Numerical solutions of this amended model suggest that for mutations affecting the response to, or causing autonomy from, biochemical regulators, there is a critical value of 8 above which the immune response prevents the growth of the tumour and causes the number of mutant cells to decay rapidly to zero, after a short initial burst of proliferation (figure 4). However, for mutations affecting only the production of chemical regulators, any positive value of < 5 causes the number of m utant cells to rapidly decrease to zero (figure 5). In Appendix 2, we present analysis which suggests that, for any model of the form (3), with biologically appropriate parameter values, the condition for the immune system to overcome the oncogenic mutation is
and this is confirmed by our extensive numerical simulations. In terms of dimensional parameters, this condition is 8 > [^0 + j 1(^) s2 (4) • Sj (c*)]. The biological interpretation of this is that, for immunosuppression of cancer, the immune system must remove m utant cells at a rate greater than the excess proliferation rate of the m utant cells over normal cells. In particular, when the mutation only affects the production of regulators, this excess pro liferation rate is zero, so that (5crit = 0. This explains the result obtained in the previous section, that when 8 = 0, mutations affecting the response to, and production of, growth regulators have quite different effects. In the former case, the system is at the critical value of when < 5 = 0. Indeed, whenever 8 = (5crit the solutions have a form that is qualitatively very similar to that shown in figure 2 . Moreover, when £ = 1 and = 0 with | 1| > 0, a negative value of 8i nduces an a of tumour cells; this is a mathematical observation with no biological relevance.
One aspect of the condition (5) that is intuitively surprising is that (5crit is independent of the number of growth regulators and of whether they act in an autocrine or paracrine way. Moreover, in the autocrine case, < 5crit is independent of the functional forms of pt{n), so that auto-regulation of growth control makes no contribution to the suppression of the advancing wave of mutant cells. These factors do, however, affect the cell density within the tumour, as illustrated in figure  6 . The tumour cell density decreases as the number of 0.6 ■ x x Figure 4 . The initial growth of a tumour cell population in the presence of an immune response, after a mutation affecting the response to a mitotic regulator, or causing partial escape from mitotic control. In (a), the immune response is not quite sufficient to suppress tumour growth, and there is an advancing wave of mutant cells and a corresponding receding wave of normal cells. In (Z>), the immune response is strong enough to suppress tumour growth, and the mutant cell density rapidly decreases; the 'gap' is rapidly filled by normal cells. We plot the density of normal and mutant cells [n and m, respectively) as functions of distance x from the site of the mutation, at equally spaced times (dimensionless time interval = 7.5); the arrows indicate the way in which the solution changes as t increases. The increase in n above zero near the origin is a purely transient phenomenon. Figure 6 . The effect of mitotic regulation on tumour cell density. We show the initial growth of a tumour cell population after the same mutation in two cases, (a) Weak mitotic regulation: two regulatory chemicals with production rates independent of cell density, (b) Strong mitotic regulation: seven regulatory chemicals whose production rates depend steeply on cell density. The tumour cell density is much higher in (a) than because of the weaker mitotic control. However, the growth rate of the tumour is approximately the same in both cases: this is a function of the mutation only. We plot the density of normal and mutant cells (n and m, respectively) as functions of distance xf rom the site of the mutation, at equally spaced times (dimensionless time interval = 3); the arrows indicate the way in which the solution changes as t increases. For brevity, we omit the concentrations of the corresponding regulatory biochemicals. The parameter values are as follows. In both ( and 3, £ = 5, = 1.5, D = 0.01, Mutations affecting the cell response to chemical regulators or resulting in autonomy from such regu lators, cause an advancing wave of tumour cells and a receding wave of normal cells. By contrast, mutations affecting the production of a mitotic regulator cause a slow localized increase in the numbers of both normal and mutant cells. Building on this understanding of the different types of mutation, we have extended our model to investigate the possible effects of an immune response to cancer by including a first order removal of mutant cells. When this removal rate exceeds a critical value, the immune system can suppress tumour growth; this critical value is equal to the difference in the mitotic rates of m utant and normal cells when the concentrations of regulatory biochemicals are at their values in normal tissue.
One of the roles of theoretical models in cell biology is to suggest ways in which experimentally charac terized molecular and genetic mechanisms might conspire to cause macroscopic phenomena. In this regard, the biological implications of our results are twofold. Firstly, our investigation of the effects of different types of m utation suggests a possible mech anism by which the expression of different oncogenes, or the loss of different anti-oncogenes, could give rise to different types of tum our growth. Secondly, our model suggests that the immune system may control tumour growth by directly counteracting the mitotic advantage of the cancer cells. Further investigation of this possibility, both experimentally and theoretically, could ultimately lead to an understanding of the factors responsible for the success or failure of imm uno therapy treatments. Now for biologically relevant param eter values, pt (n) and Pi are both 1 (except that one may be zero). 
We therefore require this inequality to hold for all /cgR, so that the steady state is stable if, and only if,
Numerical solutions of the model equations suggest that there is a critical value of the param eter which reflects the extent of the immune response to the oncogenic m utation, above which the tumour cells rapidly die off, but below which the model solutions have the form of an advancing wave of tum our cells and a corresponding receding wave of normal cells. Here we present analysis which suggests that this critical value depends on the parameters characterizing the m utation in the following w ay : 5crit = + .sy (£) -1.
We look for travelling wave solutions of (3), that is, waves with constant shape and constant speed. This implies that n (x ,t)= n (z ), q (z), where z = x + at, with a the dimensionless wave speed. Substituting these solution forms into (3) (1 ^ i < j) , where n = n-1 and q = q -1 are all 1 in absolute value. We look for plane wave solutions, n oc exp (iKX -cot), q oc exp These equations are valid on -co < z < oo, with the initial conditions n = q = 1, 0 at z = -oo. A discussed in the main body of the paper, we anticipate that D< 3; 1, while Pi +pi(n + m ) 1. We can therefore assume that, to a first order approximation, 0 and either P( = oo or hi -oo. The equations (B 1) then reduce to a system of two coupled ordinary differential equations: Moreover, as r(N) = F(N) = 0, the triangular region rc> 0, m^0 , n + m ^ N is a confined set in the n -m phase plane, and thus this trajectory must terminate within this region. Further mathematical details of this travelling wave form in a simple special case will be discussed elsewhere (Sherratt 1992 ).
